
2024-09 / MicroRNA innovation forum: New approaches in Alzheimer’s diagnostics
September 5, 2024 | CCO Auditorium, Virchowweg 6, 10117 Berlin, Germany
NeuroMiR organizes on September 5, 2024, the MicroRNA Innovation Forum at the CCO Auditorium in Berlin. This event is an important platform where groundbreaking advances in the early diagnosis of neurodegenerative diseases, especially Alzheimer’s, will be presented.
NeuroMiR is a consortium of leading research institutions and small to medium-sized enterprises (SMEs) dedicated to advancing the early diagnosis of neurodegenerative diseases. The focus is on the simultaneous measurement of specific microRNAs and protein markers in the blood of patients. This innovative approach should enable significant progress in the early diagnosis and treatment of neurodegenerative diseases.
Medipan & GA Generic Assays will contribute to this important project taking the consortium coordination. Moreover, as part of the project, we will develop a microscopy platform with associated software and we will be working on an assay for the detection of classic biomarkers in combination with microRNA markers for neurodegenerative diseases. The aim is to enable earlier and more accurate diagnosis in order to better counteract the degenerative course of the diseases.
Program:
Time | Program item |
From 2 p.m. | Get together |
3 p.m.– 4.30 p.m. | Lecture Prof. Dr. André Fischer |
4.30 p.m.– 4.45 p.m. | Lecture PD Dr. Stefan Rödiger |
4.45 p.m. – 5 p.m. | Presentation NeuroMiR – Prof. Dr. Dirk Roggenbuck |
From 5 p.m. | NeuroMiR user workshop & discussion forum |
Take the opportunity to find out about the latest developments and future possibilities in the diagnosis of neurodegenerative diseases and to exchange ideas with leading experts in this field.